|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
The Empire State Building, 350 Fifth Avenue, Room/Suite 7240, New York, New York NY 10118 , US
|
|
At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated.
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease.
Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead.
As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease.
To learn more please visit www.hookipapharma.com.
|
HOOKIPA Pharma Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
75%
|
The widely used HOOKIPA Pharma Inc. email format is {first}.{last} (e.g. [email protected]) with 75% adoption across the company.
To contact HOOKIPA Pharma Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.